{"id":"W4405696229","doi":"10.1080/14796694.2024.2442900","title":"Combination niraparib and abiraterone for HRR-altered metastatic castration-resistant prostate cancer","year":2024,"lang":"en","type":"review","venue":"Future Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Abiraterone acetate; PARP inhibitor; Androgen receptor; Enzalutamide; Oncology; Internal medicine; PARP1; Cancer research; Androgen deprivation therapy; Abiraterone; Cancer; Poly ADP ribose polymerase; Gene; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004335272,0.0004601722,0.001972553,0.0002949776,0.00009730468,0.00005109335,0.0000854363,0.0003914932,0.0001523348],"category_scores_gemma":[0.00002743482,0.0003405248,0.0002773817,0.0002863556,0.0001281639,0.00006852622,0.00002805325,0.0005106271,0.00003383762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008800747,"about_ca_system_score_gemma":0.001564467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002539163,"about_ca_topic_score_gemma":0.0001715978,"domain_scores_codex":[0.9977997,0.0002217807,0.0008244367,0.000618564,0.0001968252,0.000338705],"domain_scores_gemma":[0.9987276,0.0002011264,0.0004594042,0.0002713567,0.0001941913,0.0001462863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003997486,0.0001705958,0.000001063647,0.04805815,0.0009806574,0.00007602579,0.0004337771,2.709354e-7,0.0001159548,0.002433172,0.0433319,0.9039987],"study_design_scores_gemma":[0.002719597,0.001361066,0.000006937648,0.006085121,0.004152393,0.0002667166,0.00007985864,0.00001247256,0.00001349852,0.000578687,0.9844465,0.0002772027],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003376701,0.9879904,0.00006096929,0.003231565,0.00313781,0.004060761,0.0009758436,0.00008964475,0.0004192208],"genre_scores_gemma":[0.00003437556,0.988167,0.001256948,0.0004982025,0.001947022,0.004447368,0.001124631,0.0001088058,0.002415673],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9411145,"threshold_uncertainty_score":0.9999047,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1000884796542603,"score_gpt":0.4641938152395031,"score_spread":0.3641053355852429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}